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o r i g i n a l a r t i c l e
Healthcare-Associated Bloodstream Infections in a Neonatal
Intensive Care Unit over a 20-Year Period (1992–2011):
Trends in Incidence, Pathogens, and Mortality
Evelien Verstraete, MNSc;1 Jerina Boelens, PhD;2 Kris De Coen, MD;3 Geert Claeys, PhD;4
Dirk Vogelaers, PhD;1 Piet Vanhaesebrouck, PhD;3 Stijn Blot, PhD1
objective. To analyze trends in the incidence and pathogen distribution of healthcare-associated bloodstream infections (HABSIs) over
a 20-year period (1992–2011).
design. Historical cohort study.
setting. Thirty-two-bed neonatal intensive care unit (NICU) in a tertiary referral hospital.
patients. Neonates with HABSIs defined according to the criteria of the National Institute of Child Health and Development (NICHD).
methods. A hospital-based ongoing surveillance program was used to identify HABSI cases in neonates. A distinction between definite
or possible HABSI was made according to the NICHD criteria. Incidence, incidence densities (HABSIs per 1,000 hospital-days and HABSIs
per 1,000 total parenteral nutrition–days), and case fatality rate were calculated. Logistic regression analysis was used to find time trends.
Four periods of 5 years were considered when executing variance analysis.
results. In total, 682 episodes of HABSIs occurred on 9,934 admissions (6.9%). The median total incidence density rate was 3.1
(interquartile range, 2.2–3.9). A significant increasing time trend in incidence density was observed for the period 1995–2011 (P ! .003).
A significant decrease in the case fatality rate was found in the last 5-year period (P ! .001). No neonate died following possible HABSIs,
whereas the case fatality rate among neonates with definite HABSIs was 9.7%. Most HABSIs were caused by coagulase-negative staphylococci
(n p 414 [60.7%]). A significant increase in Staphylococcus aureus HABSI was observed in the last 10-year period (P ! .001).
conclusions. An increase in incidence density rate occurred, while the case fatality rate dropped. Better perinatal care could be responsible
for the latter. A decrease in days before infection and a high incidence of coagulase-negative Staphylococcus HABSIs indicate the need for
vigorous application of evidence-based prevention initiatives, in particular for catheter care.
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Healthcare-associated bloodstream infection (HABSI) is a fre-
quent complication in neonatal intensive care units (NICUs).
Previous studies document incidence rates ranging from 5%
to 32%.1-3 Risk factors for HABSIs include lower birth weight,
lower gestational age, prolonged mechanical ventilation
(MV), parenteral nutrition, and vascular access.3-5 For neo-
nates with very low birth weight (VLBW; 1,500 g or less),
the National Institute of Child Health and Human Devel-
opment (NICHD) reported an incidence of 21%.3
HABSIs result in longer hospitalization (plus 23 days, on
average) and a rise in mortality rate, up to 24% for VLBW
neonates.3,6-10
The past decade’s further implementation of neonatal in-
tensive care facilities has led to increasing survival rates
among preterm neonates.11,12 Neonates are of younger ges-
tational age and lower birth weight, and because of this they
might be more seriously ill. Therefore, they may be more
susceptible to HABSIs.3 Conversely, implementation of new
knowledge by means of care bundles and infection control
practices might stabilize or alter the possible increasing di-
rection.13,14
The purpose of this study was to identify trends in the
incidence densities and pathogen distribution of HABSIs over
a long period (20 years, from 1992 through 2011) in a tertiary
NICU setting to clearly define baseline data, allowing follow-
up of prevention initiatives.
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table 1. Definite, Possible, and Probable Healthcare-Associated Bloodstream Infection (HABSI), according to the Criteria of the
National Institute of Child Health and Human Development
HABSI Pathogen
No. of positive
blood cultures Other criteria
Definite Recognized (ie, Staphylococcus aureus, Enterococ-
cus spp., Escherichia coli, Pseudomonas spp.,
Klebsiella spp., Candida spp., and others)
1 None
Possible/skin contaminant (ie, Corynebacterium
spp., Bacillus [not B. anthracis] spp., Propioni-
bacterium spp., CoNS, viridans group strepto-
cocci, Aerococcus spp., and Micrococcus spp.)
2 Blood drawn within 48 h of each other (sepa-
rate occasions) and having grown the same
possible pathogen
Possible Possible/skin contaminant 1 C-reactive protein 11 mg/dL, antistaphylococcal
agent for ≥5 days
Probable Possible/skin contaminant 1 Does not meet criteria for possible
note. CoNS, coagulase-negative staphylococci.
methods
Study Design
We performed a single-center historical cohort study, con-
sidering all neonates admitted during a 20-year period (1992–
2011) whose NICU stay was complicated by at least 1 HABSI.
Files of all included cases were reviewed to determine the
diagnostic certainty of the infection. The study was approved
by the Ethics Committee of Ghent University Hospital.
Setting and Patients
Ghent University Hospital is a teaching hospital and tertiary
referral center with a 32-bed NICU. Only newborn infants
(ie, less than 28 days of life) are admitted to this unit. The
yearly mean admission rate over the past 20 years was 492
(range, 403–593), with approximately 100 (range, 95–115)
VLBW infants. Neonatal specialist services include pediatric
cardiology and cardiac surgery with, on average, 70 cases per
year, of whom 50 need surgery during the neonatal period.
During the study period there was a progressive increase in
nursing and medical staff, in accordance with the population
increase.
Infection Control Practices
Besides surveillance, no official infection control program was
implemented before 2006. The norm “good practice” was the
standard. Hand hygiene standards did not change over time
but were more visible since 2006; posters on hand hygiene
were found next to all sanitary locations. Catheter dressings
changed in July 1994 from nonpermeable to high-permeable
polyurethane dressing. A protocol for catheter care was im-
plemented in 2006 in accordance with the 2002 guidelines of
the Centers for Disease Control and Prevention (CDC).15
Case Finding
Since 1992, laboratory-based surveillance of positive blood
culture results has been performed by the infection control
team. Clinical significance, mode of transmission (ie, con-
genital, vertically transmitted [mother to infant], healthcare
associated, or community acquired), and source of infection
were determined.
The cohort is based on this ongoing surveillance program.
Since 2002, a NICAUDIT electronic database system was used
to identify additional HABSI cases and to collect demographic
and outcome data. For the present study, the following con-
ditions were collected: MV, total parenteral nutrition (TPN),
and major surgery.
Definitions
Healthcare-associated infection (HAI) is defined according to
the CDC/National Healthcare Safety Network (NHSN) cri-
teria published in 2008.1 A neonatal HAI is considered health-
care associated when it is not transplacentally transmitted,
occurs more than 48 hours after birth, and is not a reacti-
vation of a latent infection caused by, for example, herpes
zoster, herpes simplex, syphilis, or tuberculosis. To define the
diagnostic certainty of a laboratory-confirmed bloodstream
infection in patients less than or equal to 1 year of age, the
following adapted CDC/NSHN criteria were considered: (1)
a distinction was made between skin contaminant and rec-
ognized pathogens (Table 1) and (2) the blood-cultured path-
ogen could not be related to another infection site.
HABSI is defined as possible or definite according to the
NICHD criteria (Table 1).3 Blood culture results considered
as probable HABSIs are not included in our cohort. A HABSI
episode is defined as new if the same organism was cultured
after 10 days of appropriate antibiotic therapy or if a different
organism was cultured from a subsequent culture.3
Case fatality rate is the percentage of HABSI cases whose
death is related to the HABSI, on the basis of clinical judg-
ment. TPN is the intravenous administration of an admixture
of at least 2 major nutritional components (ie, carbohydrate
and amino acids or lipids).
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Blood Culture Sampling and Processing
Blood cultures were obtained through an arterial central line
or by peripheral puncture. There were no changes in blood
culture sampling policy and no significant changes in the total
number of blood cultures taken yearly during the last 10 years
of the study period (mean, 492; range, 449–555). Blood cul-
tures were assessed using the Bactec system (Becton Dick-
inson Microbiology Systems) until 1995 and the BacT/Alert
3D automated microbial detection system (bioMe´rieux) since
1996.
Occurrence Rates
Incidence is defined as the number of HABSIs per 100 ne-
onates during the 20-year study period. Incidence density is
defined as the number of HABSIs per 1,000 hospital-days,
calculated for total, definite, and possible HABSIs. The HABSI
rate in relation to vascular access is expressed by the number
per 1,000 TPN-days (ie, total TPN-days).
Statistics
Variables are described as number (%) or median (inter-
quartile range). Comparisons between groups were per-
formed using the Mann-Whitney U test (2 groups) or the
Kruskal-Wallis test (more than 2 groups) for continuous var-
iables and the x2 test for categorical variables. Four consec-
utive periods of 5 years were considered: period 1 (1992–
1996), period 2 (1997–2001), period 3 (2002–2006), and pe-
riod 4 (2007–2011). Logistic regression analysis was used to
evaluate the time trend in incidence densities during the 20-
year study period. SPSS, version 21, was used for all tests.
results
Trends in Occurrence Rates
During the study period, 9,829 neonates were admitted to
the NICU, and 682 HABSI episodes were found in 620 HABSI
cases. Respectively, 444 (65%) and 238 (35%) were definite
and possible HABSIs. Fifty-three (8.5%) of 620 HABSI cases
developed a second episode, and 9 (1.5%) of 620 HASBI cases
experienced a third episode. Characteristics, incidence, and
incidence densities (total, definite, and possible) per period
are tabulated in Table 2. Over the study period, the average
yearly incidence was 6.9 per 100 patients and ranged from
2.2 (1994) to 13.4 (1992). Total, definite, and possible inci-
dence densities are illustrated per year since no subtleties per
quartile were observed (Figure 1). The average total incidence
density rate per year was 3.1 per 1,000 hospital-days (range,
0.9–5.3).
During the study period, no overall significant trend was
observed in total, definite, and possible incidence density rates
(P p .233, .544, and .765, respectively). Because of the sub-
stantial decline observed in definite and possible incidence
density rate in 1994, a secondary logistic regression analysis
was performed for the period 1995–2011. This analysis re-
vealed a significant increasing trend in total and definite in-
cidence density rate (P p .003 and .020, respectively). Var-
iance analysis showed that the distribution of the total and
possible incidence density rate revealed no difference across
the 4 periods (Table 2). In contrast, a difference was found
in the distribution of the definite incidence density rate (P p
.040). Furthermore, a decrease was observed in days before
infection (P p .004). For periods 3 (2002–2006) and 4 (2007–
2011), incidence per 1,000 TPN-days was respectively 7.5
(6.8–9.1) and 8.1 (7.8–9.6; P p .222). HABSI incidence was
higher in particular subgroups (ie, VLBW, very low gesta-
tional age, TPN, and MV; Table 2).
Trends in Pathogen Distribution
The 682 HABSIs were caused by 717 pathogens, of which
80.2%, 18.7%, and 1.1% were gram-positive pathogens,
gram-negative pathogens, and fungi, respectively (Table 3).
Slightly more than 5% (n p 35) of the HABSIs were caused
by 2 pathogens. In 19 polymicrobial HABSIs (54.3%) coag-
ulase-negative staphylococci (CoNS) were involved, of which
17 occurred in the second 10-year period (2002–2011). Eleven
(31.4%) blood cultures revealed mixed growth with Entero-
coccus spp., of which 6 included CoNS. In the first (1992–
2001) and the second (2002–2011) 10-year period, respec-
tively, 7 (70%) of 10 and 5 (20%) of 25 polymicrobial HABSIs
involved a gram-negative pathogen. Of the 53 second-episode
HABSIs, 28 were caused by the same pathogen, of which 19
(67.9%) were CoNS, and 25 episodes were caused by 2 dif-
ferent pathogens. Pathogen distribution, divided in two 10-
year study periods, is shown in Table 3. The most common
causative pathogens were CoNS, accounting for 60.7% of all
HABSIs. Of these CoNS HABSIs, 183 (44%) were definite
and 231 (56%) were possible HABSIs. The most common
“recognized” pathogens were Enterobacteriaceae (16.0%),
Staphylococcus aureus (11.1%), and enterococci (6.2%). Pseu-
domonas spp. (2.5%) and Candida (1.2%) were rare. Six S.
aureus isolates (7.9%) were methicillin resistant.
Incidence per 1,000 hospital-days of the 4 most common
pathogens are displayed in Figure 2. CoNS remained the main
pathogens during the whole study period. As for enterococci,
S. aureus, and Enterobacteriaceae, no time trend was detected.
In contrast, variance analysis revealed an increase in S. aureus
HABSI (P ! .001) comparing the periods 1992–2001 and
2002–2011. A peak in S. aureus HABSI was found in 2005
(n p 9; 1.13 per 1,000 hospital-days), of which 4 were meth-
icillin resistant.
Two clusters (more than or equal to 3 HABSIs of the same
pathogen per week) were detected. In October 1993, 4 Pseu-
domonas aeruginosa HABSIs occurred within 3 days, and in
June 2005, 3 methicillin-resistant S. aureus (MRSA) HABSIs
occurred within 1 week.
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table 2. Epidemiological Features and Incidence Densities of Healthcare-Associated Bloodstream Infections (HABSIs) for the Four
5-Year Periods
Epidemiological feature
Total period
(1992–2011)
Period 1
(1992–1996)
Period 2
(1997–2001)
Period 3
(2002–2006)
Period 4
(2007–2011) P
Total patients, no. 9,829 2,154 2,346 2,469 2,860
Total hospital-days, no. 131,332 52,010 52,110 56,209 55,992 .095
HABSI episodes, no. (%) 682 170 (7.9) 117 (4.9) 183 (7.4) 212 (7.4) .042
HABSI cases, no. (%) 620 165 (7.7) 111 (4.7) 158 (6.4) 186 (6.5) .065
Proportion of definite HABSI, % 63 56 66 74 69 .052
Incidence, cases per 1,000 hospital-days
Total HABSI
Median (IQR) 3.1 3.2 (0.9–5.3) 1.9 (1.8–2.8) 3.1 (2.7–3.8) 3.7 (3.4–4.1) .091
Mean (range) 3.1 3.3 (4.4) 2.2 (1.2) 3.2 (1.7) 3.7 (1.1)
Definite HABSI
Median (IQR) 2 1.3 (0.9–2.5) 1.3 (1.2–1.9) 2.5 (1.8–3.0) 2.5 (2.2–3.2) .040
Mean (range) 2 1.6 (1.9) 1.5 (1.2) 2.4 (1.9) 2.6 (1.5)
Possible HABSI
Median (IQR) 1.1 1.9 (0.3–2.8) 0.6 (0.5–1.1) 0.7 (0.6–1.1) 1.1 (0.8–1.4) .327
Mean (range) 1.1 1.7 (2.5) 0.8 (0.8) 0.8 (0.7) 1.1 (1.0)
No. per 1,000 TPN-days
Median (IQR) 7.5 (6.8–9.1) 8.1 (7.8–9.6) .222
Mean (range) 7.8 (4.4) 8.7 (2.5)
Total patients with TPN, no. (days) 2,022 (24,371) 2,210 (26,124) .249
HABSI cases with TPN, no. (days) 153 (3,779) 178 (4,569) .585
HABSI cases per non-TPN patients, % 1 1 .868
Total TPN, days
Median (IQR) 20 (12–31) 19 (11–33) .914
Mean (range) 25 (194) 26 (151)
GA, weeks
Median (IQR) 33 (29–37) 33 (29–38) .853
Mean (range) 33 (18) 33 (17)
VLGA (≤31 weeks), % 42 41 .886
HABSI cases per VLGA patients, % 9 10 .614
HABSI cases per non-VLGA patients, % 5 5 .931
Birth weight, g
Median (IQR) 1,835 (1,240–2,840) 1,755 (1,100–3,025) .700
Mean (range) 2,004 (4,470) 1,999 (3,545)
VLBW (≤1,500 g), % 39 43 .565
HABSI cases per VLBW patients, % 12 15 .235
HABSI cases per non-VLBW patients, % 5 5 .571
Male sex, % 60 54 .391
Length of stay, days
Median (IQR) 41 (21–72) 37 (20–75) .555
Mean (range) 54 (249) 52 (189)
Total patients with MV, no. (days) 1,058 (7,035) 975 (6,339) .181
HABSI cases with MV, no. (days) 111 (1,313) 120 (1,643) .250
HABSI cases per non-MV patients, % 3 4 .797
Duration of MV, days
Median (IQR) 4 (0–13) 3 (0–11) .332
Mean (range) 9 (76) 9 (99)
Days before infection
Median (IQR) 10 (6–18) 8 (3–17) .004
Mean (range) 18 (138) 11 (99)
Inborn, % (proportion IUT, %) 46 (70) 48 (77) .777
Major surgery, % 29 42 .055
Case fatality rate, no. (%) 38 (6.1) 12 (7.2) 10 (8.9) 12 (7.5) 4 (2.1) !.001
note. Days before infection are the days since birth until infection. GA, gestational age; IQR, interquartile range; IUT, intrauterine transfer;
MV, mechanical ventilation; TPN, total parenteral nutrition; VLBW, very low birth weight; VLGA, very low gestational age.
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figure 1. Number of total, definite, and possible healthcare-associated bloodstream infections (HABSIs) per 1,000 hospital-days (incidence
densities) from 1992 through 2011.
Outcomes Associated with HABSIs
Thirty-eight of 620 HABSI cases died because of HABSI (6.1%
case fatality rate). No neonates of the entire possible HABSI
group (n p 229) died because of a HABSI, so deaths occurred
in the definite HABSI group (n p 391; 9.7% case fatality
rate). Considering the 4 periods, a significant decrease in the
case fatality rate was found (P ! .001).
No significant difference was found between 2002–2006
and 2007–2011 in case fatality rate for VLBW patients versus
non-VLBW patients and for surgical patients versus non-
surgical patients (data not shown). The causative pathogens
and their association with mortality are tabulated in Table 3.
In the group with polymicrobial HABSIs 2 neonates died (2/
35 [5.7%]), which was not different from the monomicrobial
HABSI group (36/647 [5.6%]; P p .972).
discussion
We reviewed trends in incidence density of HABSIs in a ter-
tiary NICU setting over a 20-year period. A statistically sig-
nificant increase in total and definite incidence density rate
was found during the period 1995–2011. A relative increase
in S. aureus HABSIs was observed in the last 10 years. No
further changes in pathogen distribution occurred. The case
fatality rate significantly decreased in the last 5 years.
Trends in Occurrence Rates
An incidence of 6.9 per 100 neonates and an incidence density
rate of 3.1 per 1,000 hospital-days indicate that HABSIs re-
main an important issue in our NICU. Because of a large
variety of case definitions, a wide range in incidence and
incidence density rates was observed when reviewing litera-
ture, thereby hampering benchmarking. Future research
should consider the use of a uniform case definition for the
surveillance of HABSI, such as the one developed by Modi
et al.16 Additionally, NICU departments should participate in
an (inter)national surveillance network to facilitate bench-
marking.16-19
During the entire study period, fluctuations in incidence
densities were observed, but no overall trend in total HABSI
incidence density was found (1992–2011). In contrast, an
increasing trend was found for the period 1995–2011. This
secondary logistic regression analysis was made to exclude
the 2 extreme incidence density values, that is, 5.3 (1992)
and 0.9 (1994). In 1994, a randomized controlled trial of
catheter care was conducted. During the 6 months of inter-
vention, the overall HABSI rate dropped tremendously. The
investigators assumed that a Hawthorne effect caused this
favorable decline.20 Similar effects are described when starting
up surveillance of HABSIs.13,17 Strict adherence to the study
protocol might be another explanation for the observed de-
cline. Before 1994, we may assume that no attention was paid
to HABSIs, which might be responsible for the higher inci-
dence density rates in 1992–1993.
Variance analysis revealed an increase across the 4 periods
for the definite incidence density rate. Increasing survival
rates of the preterm newborns during the last decades could
be associated with this finding.
It is acknowledged that the criteria of the NICHD may
overestimate true rates of CoNS HABSIs.3 In this study, no
distinction was made between the different CoNS (S. epi-
dermidis, S. hominis, etc), so an overestimation of the category
of definite CoNS HABSIs is likely. However, classification as
definite or possible was made retrospectively, and the 2
backup systems (ie, medical files and NICAUDIT) were avail-
able only since 2002. Considering these factors, misclassifi-
cation before 2002 is plausible, skewing classification toward
possible CoNS HABSIs. Nevertheless, only laboratory-con-
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table 3. Frequencies and Associated Mortality for the Main Gram-Positive and Gram-Negative Pathogens
Pathogen
Total period
(1992–2011)
Period 1  2
(1992–2001)
Period 3  4
(2002–2011)
Associated
mortality
Total pathogens 717 (100) 299 (41.7) 418 (58.3) 40 (5.6)
Coagulase-negative staphylococci 414 (57.7) 186 (62.2) 228 (54.5) 3 (7.5)
Staphylococcus aureus 76 (10.6) 17 (5.7) 59 (14.1) 3 (7.5)
Enterococcus spp. 42 (5.9) 15 (5.0) 27 (6.5) 0
Other gram-positive pathogens 43 (6.0) 11 (3.7) 32 (7.7) 0
Escherichia coli 35 (4.9) 14 (4.7) 21 (5.0) 8 (20.0)
Enterobacter spp. 46 (6.4) 24 (8.0) 22 (5.3) 14 (35.0)
Klebsiella spp. 22 (3.1) 10 (3.3) 12 (2.9) 4 (10.0)
Pseudomonas spp. 17 (2.4) 14 (4.7) 3 (0.7) 4 (10.0)
Other gram-negative pathogens 14 (2.0) 7 (2.3) 7 (1.7) 3 (7.5)
Candida spp. 8 (1.1) 1 (0.3) 7 (1.7) 1 (2.5)
Total gram-positive pathogens 575 (80.2) 229 (76.6) 346 (82.8) 6 (15.0)
Total gram-negative pathogens 134 (18.7) 69 (23.1) 65 (15.6) 33 (82.5)
Polymicrobial HABSIs, no. 35 10 25 2
note. Data are no. (%), unless otherwise indicated. HABSI, healthcare-associated bloodstream infection.
firmed HABSIs are included in this cohort, favoring under-
estimation of the true HABSI rate.
TPN-days were used to express incidence in relation to
vascular access, since the number of total catheter-days was
not available. Consequently, an overestimation of the HABSI
rate in relation to vascular access is likely. The denominator
TPN-days has already been proposed as a higher standard
than catheter-days, and, although not an apt proxy, it may
be more appropriate in defining days at risk.4,18 In our cohort,
we observed that almost all HABSI cases of period 3  4
received TPN (n p 331/344 [96.2%]) and MV (n p 231/
344 [67%]). For both devices and for the 2 periods, a sig-
nificant difference was found in the proportion HABSI cases
per device versus HABSI cases per nondevice. This obser-
vation might confirm that TPN and MV are major risk fac-
tors. Note that MV may be instituted after HABSI, so MV
statistics could be biased.
We could not discern any changes in characteristics of the
HABSI cohort. It should be noted that data were missing for
the period 1992–2001. However, for the period 2002–2011
there was a decrease in days before infection; in particular,
the lower quartile was halved. On the basis of observations
made in an adult ICU, Zingg et al19 hypothesized that faster
occurrence of infection might imply issues with catheter care,
that is, adherence to or adoption of insertion bundles. This
can also be valid for an NICU setting. Another NICU study
of Zingg et al21 showed that catheter indwelling time is a risk
factor for HABSI and clinical sepsis, so time to infection
should be placed in the context of exposure and type of
catheter.
Trends in Pathogen Distribution
HABSIs caused by CoNS, Enterococcus spp., and Enterobac-
teriaceae remained stable during the study period. Only for
S. aureus was an increase observed. In 2005 an MRSA out-
break occurred, which could be responsible for the S. aureus
HABSI increase. Nevertheless, the incidence of S. aureus
HABSIs remained low: 17 (0.3%) of 5,449 admissions in the
first 10-year period versus 59 (1.3%) of 4,380 admissions in
the last decade. The National Nosocomial Infections Sur-
veillance System reported a 13% increase in healthcare-
associated S. aureus infections among all birth-weight cate-
gories and a 308% increase in healthcare-associated MRSA
infections (31% bloodstream infections) during 1995–2004.22
As in our research, the S. aureus HABSI increase was more
pronounced since 2002. However, besides the MRSA outbreak
in 2005, no high incidence of MRSA HABSIs was noticed in
our NICU compared with other European countries.23
As in other studies, CoNS are the most common causative
pathogens for HABSIs in our NICU.2,3,24-28 The relationship
between CoNS HABSIs and vascular access is well known.
Therefore, prevention strategies need to be directed at im-
proving hand hygiene, skin-disinfection procedures, and so
on. Every blood culture positive for CoNS should raise sus-
picion of contamination. It is recognized that surveillance
according to the NICHD criteria tends to overestimate the
HABSI rate, particularly the CoNS HABSI rate. To distinguish
between contamination and true infection with a skin com-
mensal, more criteria are needed. Such criteria are proposed
by Modi et al.16 Three of 10 predefined clinical signs could
be predictive for a positive blood culture (area under the
curve p 0.83). This validated model is a nonambiguous case
definition, is practicable for clinicians, and may be more
achievable for the neonate, because no second blood culture
is required. This model will be used and tested for reliability
in our future research.
An estimation of the contaminated blood cultures might
be demonstrated by the number of mixed cultures with CoNS
or even with Enterococcus spp.16,29,30 Although enterococci are
defined as recognized pathogens according to the CDC, Free-
man et al29 are attending to the possibility that enterococci
in adults could be contaminants, particularly when mixed
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figure 2. Number of healthcare-associated bloodstream infections (HABSIs) caused by coagulase-negative staphylococci (CoNS), Staph-
ylococcus aureus, enterococci, and Enterobacteriaceae per 1,000 hospital-days from 1992 through 2011.
with skin organisms. In our cohort, 19 of 35 mixed cultures
included CoNS and 11 included Enterococcus spp., of which
6 also included CoNS. Additionally, almost all mixed cultures
with CoNS appeared in the second decade. These numbers
might reflect a high amount of contamination and indicate
the need for training programs on proper sampling tech-
niques.14,31
Trends in Outcome
A mean 6% case fatality rate reflects the importance of HABSIs
as a potential lethal complication in NICUs. However, case
fatality remains low compared with that in other studies.3,7,10
Similar findings were observed concerning the causative path-
ogens.3,7 To our knowledge, no study separately reported def-
inite and possible HABSI incidence densities and outcome
using identical NICHD criteria. One recent study by Jean-
Baptiste et al32 of neonatal CoNS infections reported definite
and possible rates but used different case definitions and did
not report mortality of CoNS HABSIs separately. Because of
our separate analysis, we may discern the importance of the
definite and possible group: the absence of mortality in the
possible group is an argument in favor of a preponderance
of contamination over true infection.
Conclusion
During the period 1995–2011 an increase in incidence density
rate occurred, while a decrease in case fatality was noticed
during the last decade. Better perinatal care might be re-
sponsible for the latter. An incidence density of 3.1 per 1,000
hospital-days on average, a decrease in days before infection,
and a high incidence of CoNS as a causative pathogen indicate
that HABSIs remain an epidemiological, diagnostic, and ther-
apeutic issue in our NICU and stress the need for vigorous
application of evidence-based prevention measures, in par-
ticular for catheter care. Our research provides baseline data
that allow benchmarking for the assessment of the effective-
ness of future prevention strategies.
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